Astellas Pharma Inc. (TYO:4503) recently announced that it has agreed to acquire Audentes Therapeutics Inc., a U.S.-based venture specializing in…...
Pharma
Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Corp. (TYO:3407) is bolstering its R&D efforts for regenerative medicine products that use induced pluripotent stem (iPS) cells,…...
KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs
KNC Laboratories Co. Ltd. (TYO:6568) is moving to bolster its business in middle-molecule drugs. The company has developed a device…...